Raf B protein kinase inhibitors (Medolution)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameRaf B protein kinase inhibitors (Medolution)
Drug Alias Namesmall molecule therapeutics (MedoLution)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase B-raf inhibitors
TargetsSerine/threonine-protein kinase B-raf
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesMedolution Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedolution Ltd
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A